Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for TCHBF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for TCHBF and 80,000+ other tickers.
See exactly how TCHBF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TCHBF and 80,000+ other tickers.
Tecan Group AG is a specialized provider of advanced laboratory instruments and comprehensive solutions, serving a diverse clientele that includes pharmaceutical and biotechnology firms, academic research institutions, and forensic and diagnostic testing facilities. The company operates through two primary divisions: the Life Sciences Business and the Partnering Business. Its extensive product portfolio features automated liquid handling systems, microplate readers and washers, various consumables, next-generation sequencing (NGS) reagents, immunoassays, microbody products, and specialized…
Tecan Group AG (TCGGY) Q2 2026 Earnings Call Transcript
MÄNNEDORF, Switzerland--(BUSINESS WIRE)--Tecan (SIX Swiss Exchange: TECN), a global provider of laboratory automation and solutions, today announced the integration of Agentic AI capabilities into its lab analytics platform Introspect, leveraging NVIDIA BioNeMo Agent Toolkit. The NVIDIA BioNeMo Agent Toolkit enables AI agents to access scientific AI capabilities directly within the Introspect platform, helping laboratories to optimize operations. Agentic AI will allow laboratories to move beyon.
Männedorf, Switzerland, March 17, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) today announced a strategic collaboration with NVIDIA focused on providing the AI-enabled platforms that Data-Driven Laboratories need to achieve faster discoveries and higher lab productivity.
Tecan Group AG (TCGGY) Analyst/Investor Day Transcript
Tecan Group AG (TCGGY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript